Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1359 ARTÍCULOS , VIENDO DEL 1336 AL 1350

Hip fracture risk and subsequent mortality among Alzheimer's disease patients in the United Kingdom, 1988-2007

Baker NL, Cook MN, Arrighi HM, Bullock R.

Age Ageing. 2011 Jan;40(1):49-54. doi: 10.1093/ageing/afq146. Epub 2010 Nov 18.

Influence of socio-demographic, clinical and functional factors on the severity of dementia

Marra TA, Pereira DS, Faria CD, Tirado MG, Pereira LS.

Arch Gerontol Geriatr. 2011 Sep-Oct;53(2):210-5. doi: 10.1016/j.archger.2010.11.001. Epub 2010 Nov 24.

Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?

Humpel C.

Exp Gerontol. 2011 Apr;46(4):225-32. doi: 10.1016/j.exger.2010.11.032. Epub 2010 Nov 26.

Reliability and validity of the Norwegian version of the Brief Agitation Rating Scale (BARS) in dementia

Sommer OH, Engedal K.

Aging Ment Health. 2011 Mar;15(2):252-8. doi: 10.1080/13607863.2010.519318. Epub 2010 Dec 6.

Development of a short form of the Boston naming test for individuals with aphasia

del Toro CM, Bislick LP, Comer M, Velozo C, Romero S, Gonzalez Rothi LJ, Kendall DL.

J Speech Lang Hear Res. 2011 Aug;54(4):1089-100. doi: 10.1044/1092-4388(2010/09-0119). Epub 2010 Dec 20.

Depression among the very old with dementia

Bergdahl E, Allard P, Gustafson Y.

Int Psychogeriatr. 2011 Jun;23(5):756-63. doi: 10.1017/S1041610210002255. Epub 2010 Dec 21.

Timing of hormone therapy and dementia: the critical window theory revisited

Whitmer RA, Quesenberry CP, Zhou J, Yaffe K.

Ann Neurol. 2011 Jan;69(1):163-9. doi: 10.1002/ana.22239. Epub 2010 Nov 12.

The role of behavior analysis in the rehabilitation of persons with dementia

Buchanan JA, Christenson A, Houlihan D, Ostrom C.

Behav Ther. 2011 Mar;42(1):9-21. doi: 10.1016/j.beth.2010.01.003. Epub 2010 Sep 21.

Applying Skinner's analysis of verbal behavior to persons with dementia

Dixon M, Baker JC, Sadowski KA.

Behav Ther. 2011 Mar;42(1):120-6. doi: 10.1016/j.beth.2010.05.002. Epub 2010 Nov 2.

Hypertension is a potential risk factor for vascular dementia: systematic review

Sharp SI, Aarsland D, Day S, Sønnesyn H; Alzheimer's Society Vascular Dementia Systematic Review Group; Ballard C.

Int J Geriatr Psychiatry. 2011 Jul;26(7):661-9. doi: 10.1002/gps.2572. Epub 2010 Dec 29.

Lack of awareness of symptoms in people with dementia: the structural and functional basis

Zamboni G, Wilcock G.

Int J Geriatr Psychiatry. 2011 Aug;26(8):783-92. doi: 10.1002/gps.2620. Epub 2010 Oct 28.

A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease

Devanand DP, Pelton GH, Cunqueiro K, Sackeim HA, Marder K.

Int J Geriatr Psychiatry. 2011 Sep;26(9):937-43. doi: 10.1002/gps.2630. Epub 2010 Dec 28.

Medicinal plants and dementia therapy: herbal hopes for brain aging?

Perry E, Howes MJ.

CNS Neurosci Ther. 2011 Dec;17(6):683-98. doi: 10.1111/j.1755-5949.2010.00202.x. Epub 2010 Oct 18.

Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's disease

Armentero MT, Sinforiani E, Ghezzi C, Bazzini E, Levandis G, Ambrosi G, Zangaglia R, Pacchetti C, Cereda C, Cova E, Basso E, Celi D, Martignoni E, Nappi G, Blandini F.

Neurobiol Aging. 2011 Dec;32(12):2142-51. doi: 10.1016/j.neurobiolaging.2010.01.004. Epub 2010 Jan 27.

Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo

Darreh-Shori T, Forsberg A, Modiri N, Andreasen N, Blennow K, Kamil C, Ahmed H, Almkvist O, Långström B, Nordberg A.

Neurobiol Aging. 2011 Dec;32(12):2320.e15-32. doi: 10.1016/j.neurobiolaging.2010.04.028. Epub 2010 Jun 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias